Shire plc (LSE: SHP, NASDAQ: SHPG) announces it was notified today that on February 14, 2014, Graham Hetherington, Chief Financial Officer, exercised a Stock Appreciation Right Award (“Award”). The Award was granted in 2010 under the Shire Portfolio Share Plan over Shire plc ordinary shares of 5p each (“Shares”).
|Number of Shares exercised||Exercise price||Number of Shares received and sold||Average sale price|
The Shares were sold on the London Stock Exchange on February 14, 2014.
This notification is to satisfy the Company’s obligations under 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.
Deputy Company Secretary
For further information please contact:
+1 781 482 0999
+44 1256 894157
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.
Click here for the PDF version of this press release.